The effects of thromboxane A2 inhibition (Picotamide) and angiotensin II receptor blockade (Losartan) in primary Raynaud's phenomenon

@article{Pancera1997TheEO,
  title={The effects of thromboxane A2 inhibition (Picotamide) and angiotensin II receptor blockade (Losartan) in primary Raynaud's phenomenon},
  author={P. Pancera and S. Sansone and S. Secchi and G. Covi and A. Lechi},
  journal={Journal of Internal Medicine},
  year={1997},
  volume={242}
}
Pancera P, Sansone S, Secchi S, Covi G, Lechi A (University of Verona, Verona, Italy). The effects of thromboxane A2 inhibition (Picotamide) and angiotensin II receptor blockade (Losartan) in primary Raynaud's phenomenon. J Intern Med 1997; 242: 373–6. 
Focus on small artery stiffness.
Renin—Angiotensin System Mediators and Raynaud's Phenomenon
Oral vasodilators for primary Raynaud's phenomenon.
Tratamiento del fenómeno de Raynaud
Raynaud's phenomenon
...
1
2
3
4
...

References

SHOWING 1-10 OF 16 REFERENCES
Effect of enalapril on the skin response to bradykinin in man.
Effect of thromboxane synthetase inhibition in Raynaud's phenomenon
Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon
Treatment of Raynaud's phenomenon with captopril.
The microcirculation and hypertension.
...
1
2
...